You have 9 free searches left this month | for more free features.

mutation screening

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion

Active, not recruiting
  • Screening Breast MRI in Patients Who Are BRCA Mutation Carriers
  • MRI
  • Optional Screening Questionnaire
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 19, 2022

(PROSPECTOR) Screening Study Evaluating Prevalence of KIT D816V

Recruiting
  • Systemic Mast Cell Activation
  • KIT D816V Mutation
  • Screening
  • Boston, Massachusetts
  • +1 more
May 5, 2022

Prostatic Tumor, Prostate Cancer, BRCA2 Mutation Trial in Boston (Prostate cancer screening)

Recruiting
  • Prostatic Neoplasm
  • +7 more
  • Prostate cancer screening
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 30, 2021

Prostate Cancer Trial in Toronto (MS3TMRI / TRUS Guided Biopsy)

Recruiting
  • Prostate Cancer
  • MS3TMRI / TRUS Guided Biopsy
  • Toronto, Ontario, Canada
    Sunnybrook Odette Cancer Centre
May 5, 2022

Pancreas Cancer, Peutz-Jeghers Syndrome (PJS), Gene Mutation Trial in United States (drug, diagnostic test, other)

Recruiting
  • Pancreas Cancer
  • +4 more
  • New Haven, Connecticut
  • +7 more
Dec 12, 2022

Breast Cancer Female, BRCA1 Mutation, BRCA2 Mutation Trial in Paris, Clermont-Ferrand, Beaumont (liquid biopsy)

Recruiting
  • Breast Cancer Female
  • +2 more
  • liquid biopsy
  • Paris, Ile De France, France
  • +5 more
Mar 24, 2022

Ovarian Carcinoma Trial in Evanston, Houston (other, procedure, behavioral)

Active, not recruiting
  • Ovarian Carcinoma
  • Ovarian Cancer Screening
  • +5 more
  • Evanston, Illinois
  • +1 more
Feb 3, 2022

Endometrial Adenocarcinoma, Endometrial Carcinoma, Lynch Syndrome Trial in United States (Genetic Counseling, Genetic Testing,

Active, not recruiting
  • Endometrial Adenocarcinoma
  • +3 more
  • Genetic Counseling
  • +3 more
  • Akron, Ohio
  • +8 more
Dec 2, 2022

Identification of a Genetic Predisposition to ProstAte Cancer

Active, not recruiting
  • Prostate Cancer in BRCA1 and BRCA2 Carriers
  • PSA test
  • Prostate Biopsy
  • Sutton, Surrey, United Kingdom
    Cancer Genetics Unit, Royal Marsden Hospital
Mar 30, 2022

Ex Vivo Drug Sensitivity Testing and Mutation Profiling

Completed
  • Recurrent Childhood Acute Myeloid Leukemia
  • +13 more
    • Miami, Florida
      Nicklaus Children's Hospital
    Jan 18, 2023

    Cascade Testing in Families With Newly Diagnosed Hereditary

    Recruiting
    • BRCA-Mutated Ovarian Carcinoma
    • +7 more
    • CASCADE genetic screening
    • New York, New York
      NYU Langone Health
    Apr 30, 2021

    Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial (Azacitidine, Biospecimen Collection, Bone Marrow Aspiration)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome
    • (no location specified)
    Jan 13, 2023

    Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers

    Completed
    • Pulmonary Arterial Hypertension
      • Le Kremlin-Bicêtre, France
        David Montani
      Jan 12, 2021

      Functional Test for Mediterranean Family Fever Screening - 2

      Recruiting
      • Familial Mediterranean Fever
      • MEFV Gene Mutation
      • one additional blood sample during a planned blood test
      • Bron, France
      • +7 more
      Nov 15, 2021

      Utilizing Free DNA in Embryo Culture for PGT

      Completed
      • Chromosome Abnormalities
      • +2 more
      • NGS reading for Media Free DNA
      • (no location specified)
      Aug 13, 2021

      Abbreviated Breast MRI for Second Breast Cancer Detection in

      Recruiting
      • Breast Cancer
      • +4 more
        • Seoul, Korea, Republic of
          Seoul National University Hospital
        Nov 26, 2020

        NSCLC, Non-squamous Non-small-cell Lung Cancer, Non-Squamous Non-Small Cell Tumor of Lung Trial in United States (Liquid Biopsy

        Active, not recruiting
        • Non-Small Cell Lung Cancer
        • +5 more
        • Liquid Biopsy NGS Test
        • Daphne, Alabama
        • +62 more
        Nov 5, 2021

        Cystic Fibrosis, Pulmonary Trial in Shanghai (Sweat Test)

        Recruiting
        • Cystic Fibrosis, Pulmonary
        • Sweat Test
        • Shanghai, Shanghai, China
          Shanghai pulmonary hospital
        Oct 31, 2022

        Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor Trial (drug, procedure, biological)

        Not yet recruiting
        • Advanced Malignant Solid Neoplasm
        • Locally Advanced Malignant Solid Neoplasm
        • (no location specified)
        Dec 2, 2022

        Mutation, Genetic Syndrome Trial in Le Kremlin-Bicêtre (Screening of adult without diagnosis of PH carrying an heterozygous

        Unknown status
        • Mutation
        • Genetic Syndrome
        • Screening of adult without diagnosis of PH carrying an heterozygous EIF2AK4 mutation.
        • Le Kremlin-Bicêtre, Krémlin Bicêtre, France
          David MONTANI
        Jan 17, 2020

        Dent Disease Trial in Rochester (Genetic Analysis)

        Completed
        • Dent Disease
        • Genetic Analysis
        • Rochester, Minnesota
          Mayo Clinic
        Apr 2, 2020

        Colorectal Cancer Early Screening in China

        Completed
        • Colorectal Cancer
        • +3 more
        • Multitarget stool FIT-DNA test - ColoClear
        • +2 more
        • Zhengzhou, Henan, China
        • +7 more
        Dec 7, 2020

        Screening for Fabry Disease in Renal Transplantation

        Unknown status
        • Fabry Disease
        • Nephropathy
        • Screening for Fabry disease
        • Screen for α-galactosidase mutation
        • Montpellier, France
          Uh Montpellier
        Jan 6, 2020

        The Prevelence of HBB c.93-21 G-A in ß Thalassemia Patients

        Recruiting
        • Beta-Thalassemia
        • ARMS PCR
        • Assiut, Egypt
          Faculty of Medicine Assiut University
        Jan 30, 2023

        Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

        Recruiting
        • Advanced Malignant Solid Neoplasm
        • +44 more
        • Biopsy
        • +23 more
        • Birmingham, Alabama
        • +166 more
        Feb 2, 2023